Sen. Thom Tillis

Maddy summaryThe Medical Supply Chain Resiliency Act (S 998) aims to strengthen U.S. access to critical medical goods by creating "trusted trade partner agreements" with foreign countries that meet specific criteria, such as maintaining open trade during health emergencies and protecting intellectual property. It directly affects the U.S. Trade Representative, foreign governments, and medical manufacturers by reducing tariffs and trade barriers for medical devices and pharmaceuticals with these partners. Key mechanisms include establishing a framework to diversify supplier networks, harmonize regulatory standards, and expedite cross-border movement of medical goods during crises. The bill requires the President to submit regular reports to Congress and mandates that agreements must be approved by Congress before taking effect.

Maddy summaryThis bill reauthorizes a federal program supporting pregnant and postpartum women with substance use disorders. It increases annual funding from $29.9 million to $38.9 million for fiscal years 2025-2029, updates terminology to "health care services," and requires applicants to include outreach plans targeting women disproportionately impacted by maternal substance use disorder. The program directly affects eligible women seeking treatment during pregnancy and postpartum, ensuring continued access to care through expanded funding and targeted outreach. The changes apply to the existing Public Health Service Act program (Section 508) without altering its core purpose.

Maddy summaryThe SOIL Act of 2025 requires the Committee on Foreign Investment in the United States (CFIUS) to review certain foreign purchases of agricultural land and real estate near military bases. It specifically targets transactions involving foreign entities from countries designated as nonmarket economies (like China or Russia under trade law) or identified as national security risks in the annual intelligence threat report. The bill prohibits federal subsidies for agricultural land held by such foreign entities and updates disclosure rules to include long-term leases of agricultural land. It also mandates annual public reports detailing foreign ownership of U.S. farmland by country, including holdings near military installations within 50 miles.

Veterans 2nd Amendment Protection Act of 2025 This bill prohibits the Department of Veterans Affairs (VA) from transmitting certain information to the National Instant Criminal Background Check System (NICS) utilized by licensed importers or dealers of firearms. Specifically, the bill prohibits the VA from transmitting personally identifying information of a veteran or a beneficiary to the NICS solely on the basis that such veteran or beneficiary has an appointed fiduciary to manage their benefits, unless there is an order or finding of a judicial authority that such veteran or beneficiary is a danger to themselves or others.

Maddy summaryThe Restore VA Accountability Act of 2025 establishes new rules for disciplining VA supervisors and management officials (excluding senior executives and political appointees) for poor performance or misconduct. It requires the VA Secretary to use specific, written criteria - like the offense's severity, the employee's role, and past record - when deciding on removal, demotion, or suspension, and mandates decisions within 15 business days. The bill creates an internal grievance process for affected employees and strengthens whistleblower protections by requiring Special Counsel approval before disciplining someone who disclosed wrongdoing. It also limits judicial review to cases of arbitrary or capricious decisions and explicitly prohibits courts from reducing penalties. The law applies to VA employees covered under the bill's definition, effective from the 2017 VA Accountability Act's enactment date.

Maddy summarySRES 121 establishes the Senate Human Rights Commission, a bipartisan forum for discussing international human rights issues. The 10-member commission (5 from each party, led by two co-chairs) will hold hearings, monitor global human rights violations, and collaborate with other groups - but it has no legislative power or authority to draft bills. Funded with a $200,000 annual cap from the Senate’s Contingent Fund, the commission will sunset on January 1, 2029. It directly affects Senate members appointed to serve and builds on the existing Senate Human Rights Caucus.

Maddy summaryThis bill requires all U.S. flags displayed on federal property or purchased by federal agencies to be "made in the United States," defined as 100% manufactured in the U.S. from U.S.-produced materials. Federal agencies must comply with this rule for flag procurement within 90 days of enactment and for display within two years. The bill also directs the Federal Trade Commission to study current country-of-origin labeling enforcement for flags and report findings within one year. It explicitly excludes private entities from these requirements. The law aims to ensure federal flag use supports domestic manufacturing, with no impact on private flag sales or displays.

Maddy summaryThis bill amends the 2022 Camp Lejeune Justice Act to clarify and improve legal procedures for individuals exposed to contaminated water at Camp Lejeune. It updates the required proof of harm to include "latent or potential harm" and lowers the minimum required presence at Camp Lejeune from 30 consecutive days to any 30 days. The bill also specifies that cases must be filed in the Eastern District of North Carolina (with optional transfer to the 4th Circuit), mandates jury trials upon request, and sets attorney fee caps at 20% for pre-litigation settlements and 25% for cases filed after litigation begins. It directly affects individuals filing claims under the Camp Lejeune Justice Act for health issues linked to water contamination.

Maddy summaryThe EPIC Act of 2025 extends the required time period for negotiating drug prices under the federal program for biologic drugs. It changes the rule so that biologic drug manufacturers must wait at least 11 years after FDA approval before their drug can be included in price negotiations, starting with the 2028 initial price applicability year. This specifically affects biologic drug manufacturers, as the change applies only to biologics (not small-molecule drugs, which already have different rules). The bill modifies Section 1192(e)(1)(A)(ii) of the Social Security Act to implement this longer waiting period. This is a concrete policy change to the timing of drug price negotiations, not a new program or broader policy shift.

Maddy summaryThis bill increases tax benefits for working families by expanding child care tax credits. It raises the employer-provided child care credit from 25% to 50% of qualified expenses (with the maximum credit increasing from $150,000 to $500,000), and adds a new refundable household care credit allowing up to 50% of eligible expenses (capped at $5,000 for one child or $8,000 for two+ children). Small businesses receive enhanced benefits, with a 60% credit rate and higher maximum ($600,000) for qualifying employers. The changes directly affect working parents, caregivers, and small businesses that provide or support child care.